Europe Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2027

Key Highlights

• The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
• The European pharmaceuticals market had total revenues of $353.5 billion in 2022, representing a compound annual growth rate (CAGR) of 4.6% between 2017 and 2022.
• 0
• The European region acquired a 27.2% share of the global pharmaceuticals market in 2022. The growth in the pharmaceuticals market is mainly due to an increase in pharmaceutical spending by the government. According to the most recent data available from the OECD, pharmaceutical spending in the UK stood at 9.5% of total health spending in 2021.

Scope

• Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the pharmaceuticals market in Europe
• Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
• Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
• Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts by both value and volume

Reasons to Buy

• What was the size of the Europe pharmaceuticals market by value in 2022?
• What will be the size of the Europe pharmaceuticals market in 2027?
• What factors are affecting the strength of competition in the Europe pharmaceuticals market?
• How has the market performed over the last five years?
• What are the main segments that make up Europe's pharmaceuticals market?